Eli Lilly's Zepbound: The New Weight Loss Drug Now Available at US Pharmacies

Eli Lilly has announced that its weight loss medication, Zepbound, is now available for use. The drug contains tirzepatide, which was initially approved by the FDA for treating type 2 diabetes. Last month, it received FDA approval for chronic weight management. Zepbound is intended for adults with obesity or those who are overweight and have weight-related medical problems. The medication mimics two hormones to reduce appetite and slow stomach emptying. It will be available in six doses and should be used in combination with a reduced-calorie diet and increased physical activity. Zepbound has shown significant weight loss results in clinical trials, but it has potential side effects and warnings. The cost of Zepbound is around $1,060 per month, but a savings card is available for those with commercial insurance.